BACKGROUND: Impaired liver function tests and co-infection with hepatitis viruses in AIDS patients are common in western countries. OBJECTIVE: To assess liver function and prevalence of co-infection with hepatitis B and hepatitis C viruses in AIDS patients at Chris Hani Baragwanath Hospital. DESIGN: A prospective study. SETTING: Chris Hani Baragwanath Hospital, Johannesburg, South Africa. PATIENTS: One hundred consecutive patients with AIDS admitted to Chris Hani Baragwanath Hospital. RESULTS: There were 52 males and 48 females aged 16 to 54 years (mean + SD: 34.6 + 7.5 years). The results of laboratory test were as follows: LFTs: bilirubin 11.8 (+15.6) mumol/l; AST: 79.6 (+/- 116.6) iu/L; alkaline phosphatase: 204.3 (+/- 237.4) i mu/L; albumin: 23.9 (+/- 6.2) g/l; CD4+ lymphocytes: 141.5 (+/- 168.6) microliters; CD8+: 666.9 (+/- 618.3) microliters; HBV - HbsAg: 6 (6%); HbsAg + eAg: 3 (3%); previous disease (Anti HBs and/or anti HBc): 35%, HCV: 1(1%). CONCLUSION: Liver function tests were impaired in the majority of patients with AIDS (93%) in our setting. Evidence of previous and present HBV infection was present in 41%. This is different from what is observed in western countries (90-95%). The results also suggest that patients here acquired HBV infection while still immuno competent. HCV infection was rare.
BACKGROUND: Impaired liver function tests and co-infection with hepatitis viruses in AIDSpatients are common in western countries. OBJECTIVE: To assess liver function and prevalence of co-infection with hepatitis B and hepatitis C viruses in AIDSpatients at Chris Hani Baragwanath Hospital. DESIGN: A prospective study. SETTING: Chris Hani Baragwanath Hospital, Johannesburg, South Africa. PATIENTS: One hundred consecutive patients with AIDS admitted to Chris Hani Baragwanath Hospital. RESULTS: There were 52 males and 48 females aged 16 to 54 years (mean + SD: 34.6 + 7.5 years). The results of laboratory test were as follows: LFTs: bilirubin 11.8 (+15.6) mumol/l; AST: 79.6 (+/- 116.6) iu/L; alkaline phosphatase: 204.3 (+/- 237.4) i mu/L; albumin: 23.9 (+/- 6.2) g/l; CD4+ lymphocytes: 141.5 (+/- 168.6) microliters; CD8+: 666.9 (+/- 618.3) microliters; HBV - HbsAg: 6 (6%); HbsAg + eAg: 3 (3%); previous disease (Anti HBs and/or anti HBc): 35%, HCV: 1(1%). CONCLUSION: Liver function tests were impaired in the majority of patients with AIDS (93%) in our setting. Evidence of previous and present HBV infection was present in 41%. This is different from what is observed in western countries (90-95%). The results also suggest that patients here acquired HBV infection while still immuno competent. HCV infection was rare.
Entities:
Keywords:
Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Clinical Research; Developing Countries; Diseases; English Speaking Africa; Hepatitis; Hiv Infections; Liver Dysfunction; Prospective Studies; Research Methodology; Research Report; South Africa; Southern Africa; Studies; Viral Diseases
Authors: Cynthia Firnhaber; Anne Reyneke; Doreen Schulze; Babatyi Malope; Mhairi Maskew; Patrick MacPhail; Ian Sanne; Adrian Di Bisceglie Journal: S Afr Med J Date: 2008-07
Authors: Ponsiano Ocama; Michael Katwere; Theresa Piloya; Jordan Feld; Kenneth C Opio; Andrew Kambugu; Elly Katabira; David Thomas; Robert Colebunders; Allan Ronald Journal: Afr Health Sci Date: 2008-03 Impact factor: 0.927
Authors: Cynthia Firnhaber; Raquel Viana; Anne Reyneke; Doreen Schultze; Babatyi Malope; Mhairi Maskew; Adrian Di Bisceglie; Patrick MacPhail; Ian Sanne; Michael Kew Journal: Int J Infect Dis Date: 2008-12-09 Impact factor: 3.623
Authors: Duncan Ndegwa Maina; Andrew Kimanga Nyerere; Ruth Wambui Gicho; Joseph Maina Mwangi; Raphael Wekesa Lihana Journal: East Afr Health Res J Date: 2017-07-01